These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 1405364

  • 1. Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?
    Keane WF, St Peter JV, Kasiske BL.
    Kidney Int Suppl; 1992 Oct; 38():S134-41. PubMed ID: 1405364
    [Abstract] [Full Text] [Related]

  • 2. [Disturbances of lipid metabolism during nephrotic syndrome: physiopathology and treatment].
    Moulin B, Ollier J, Olmer M.
    Nephrologie; 1992 Oct; 13(5):193-9. PubMed ID: 1470293
    [Abstract] [Full Text] [Related]

  • 3. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis.
    Kes P.
    Acta Med Croatica; 2001 Oct; 55(4-5):177-86. PubMed ID: 12398021
    [Abstract] [Full Text] [Related]

  • 4. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis].
    Kes P, Reiner Z, Brunetta B.
    Lijec Vjesn; 2002 Oct; 124(11-12):372-7. PubMed ID: 12679979
    [Abstract] [Full Text] [Related]

  • 5. The hyperlipidemia of the nephrotic syndrome.
    Appel GB, Valeri A, Appel AS, Blum C.
    Am J Med; 1989 Nov; 87(5N):45N-50N. PubMed ID: 2486547
    [Abstract] [Full Text] [Related]

  • 6. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 Nov; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 7. Dietary cholesterol induced changes in lipid profile in patients with nephrotic syndrome and chronic renal failure.
    Jain PK, Arora RC, Agarwal N, Garg RK, Arora S, Gurbaxani RK, Sharma D.
    J Assoc Physicians India; 1991 Oct; 39(10):751-3. PubMed ID: 1816199
    [Abstract] [Full Text] [Related]

  • 8. Pathogenesis of lipid abnormalities in patients with nephrotic syndrome/proteinuria: clinical implications.
    Warwick GL, Packard CJ.
    Miner Electrolyte Metab; 1993 Oct; 19(3):115-26. PubMed ID: 8232098
    [Abstract] [Full Text] [Related]

  • 9. [Carotid artery thrombosis and myocardial infarction in nephrotic syndrome].
    Nigond J, Grolleau-Raoux R.
    Arch Mal Coeur Vaiss; 1990 Jan; 83(1):105-8. PubMed ID: 2106297
    [Abstract] [Full Text] [Related]

  • 10. Rationale and management of hyperlipidemia of the nephrotic syndrome.
    Grundy SM, Vega GL.
    Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542
    [Abstract] [Full Text] [Related]

  • 11. Increased high density lipoprotein cholesterol in adult nephrotic syndrome in Nigeria.
    Adigun MO, Agbedana EO, Kadiri S, Taylor GO.
    Afr J Med Med Sci; 1999 Nov; 28(1-2):97-100. PubMed ID: 12953996
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Nov; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Proteinuria, hyperlipidemia, and the kidney.
    Hutchison FN.
    Miner Electrolyte Metab; 1993 Nov; 19(3):127-36. PubMed ID: 8232099
    [Abstract] [Full Text] [Related]

  • 19. Lipid abnormalities in the nephrotic syndrome: causes, consequences, and treatment.
    Wheeler DC, Bernard DB.
    Am J Kidney Dis; 1994 Mar; 23(3):331-46. PubMed ID: 8128933
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.